-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Prime Medicine, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q3 2021 to Q2 2024.
- Prime Medicine, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$55.7M, a 23% decline year-over-year.
- Prime Medicine, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$224M, a 43.6% decline year-over-year.
- Prime Medicine, Inc. annual Operating Income (Loss) for 2023 was -$205M, a 75.7% decline from 2022.
- Prime Medicine, Inc. annual Operating Income (Loss) for 2022 was -$117M, a 38% decline from 2021.
- Prime Medicine, Inc. annual Operating Income (Loss) for 2021 was -$84.5M, a 8964% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)